IONS Ionis Pharmaceuticals, Inc.

$54.21▼ -2.59% Healthcare Other
After hours $54.34▲ +0.24% Sep 11, 7:52 PM ET
Volume 2.17M Avg Volume (10D) 3.15M
Key Metrics & Fundamentals
Market Cap
$9.01B
P/E Ratio
–
Div Yield
–%
52W Range
50.01 - 86.74
% vs 50 MA
-8.55%
% vs 200 MA
-25.78%
RSI-14
35.5
MACD Histogram
-0.6100
Beta (1Y vs SPY)
0.36
Free Cash Flow
$547.30M
Gross Rev
$267.95M
Gross Profit
$265.21M
EBITDA
-$95.29M
COGS
$2.74M
Operating Exp
$367.51M
Operating Income
-$102.30M
EBIT
-$102.30M
Pretax Income
-$113.38M
Net Income
-$114.65M
EPS (Diluted)
-0.69
Price & Volume History
Loading chart…
Recent News
Ionis Has Its First Neurology Launch, But Can Zanvastro Justify Its $285,000 Price?
Insider Monkey · Sep 11, 2026 10:22 PM
BofA Sees Limited Damage from Novartis (NVS)’ Pelacarsen Miss While Citi Looks Towards Ionis (IONS)
Insider Monkey · Sep 11, 2026 1:06 AM
Royalty Pharma (RPRX): Can Downside Protection Offset Pelacarsen’s Phase 3 Failure?
Insider Monkey · Sep 10, 2026 6:20 PM
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
Motley Fool · Sep 9, 2026 8:50 PM
Theravance Bio (TBPH) Up 0.8% Since Last Earnings Report: Can It Continue?
Zacks · Sep 9, 2026 3:30 PM
BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93
MT Newswires · Sep 9, 2026 12:15 PM
How Novartis' Double-Stacked Failures Reverberated Through Biopharma
Investor's Business Daily · Sep 8, 2026 8:26 PM
Novartis Stock Tanks Following Third Major Pipeline Setback
Barrons.com · Sep 8, 2026 8:26 PM
NVS Stock Clocks Worst Day In Over 20 Years After Second Trial Failure In A Week — DYN, SRPT Slip In Sympathy
Stocktwits · Sep 8, 2026 8:09 PM
Royalty Pharma Shares Fall After Novartis' Pelacarsen Fails Trial
MT Newswires · Sep 8, 2026 8:04 PM
Financial Overview - Income Statement Quarterly

See IONS's money flow as a full page

Social Sentiment
Avg +0.46 · 6 posts
NewsEarningsTradeDiscussionIonis director bought about $1M of stock right after Q2, the day the market ignored an earnings beat
r/StockMarket · Aug 3, 2026
The director's large purchase after an earnings beat suggests confidence, despite market reaction.
positive +0.60
NewsTradeDDIONS is About to Break Out
r/wallstreetbets · Aug 19, 2025
The post expresses strong bullish sentiment regarding IONS' upcoming FDA approval and market potential.
very_positive +1.00
$ENVX Enovix Corp undertaking transformative battery tech
r/stocks · Jul 22, 2025
While cautious, the author expresses optimism about IONS and acknowledges a significant potential opportunity if the company succeeds, indicating positive sentiment.
positive +0.60
IonQ’s Oxford Ionics Acquisition: The Quantum Leap No One’s Talking About (But Should Be)
r/stocks · Jun 10, 2025
The comments express significant concerns about dilution, cash burn, and the lack of viable use cases, indicating a bearish sentiment toward IONS.
negative -0.60
TradeHow are these buys? New to buying individual stocks.
r/investing · Mar 25, 2025
The author states they've bought IONS, indicating a positive view.
positive +0.70
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙